pregnancy. Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
Conditions
Interventions
Intervention 1: In intervention group: Administration of 80 mg Aspirin tablet daily until 34th week of gestation. Intervention 2: control group: no aspirin administration.
Treatment - Drugs
In intervention group: Administration of 80 mg Aspirin tablet daily until 34th week of gestation.
control group: no aspirin administration.
Sponsors
Vice chancellor for research, Kerman University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: pregnant women with abnormal biochemical tests in second trimester which have normal karyotype; consent of the patients. Exclusion criteria: history of sensitivity to aspirin; asthma; Peptic ulcer; renal failure; gout; multifetal pregnancy; gestational diabetes; hemorrhage in first half of pregnancy; maternal disorders; congenital anomalies.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preterm labor. Timepoint: at birthday. Method of measurement: calculated from the number of completed weeks since the first day of the mother's last menstrual period to the date of birth.;Fetal death. Timepoint: during pregnancy. Method of measurement: examination of fetus.;Intra uterine Growth Restriction. Timepoint: after delivery. Method of measurement: based on age and weight.;Preeclampsia. Timepoint: every two weeks. Method of measurement: patient visit and blood pressure checking.;Placental abruption. Timepoint: at birthday. Method of measurement: examination of fetus. | — |
Secondary
| Measure | Time frame |
|---|---|
| Oligohydramnios. Timepoint: during pregnancy. Method of measurement: examination of fetus. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactManijeh Assaran
Kerman University of Medical Sciences
Outcome results
None listed